Compare STIM & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | OPRX |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 117.1M |
| IPO Year | 2018 | 2008 |
| Metric | STIM | OPRX |
|---|---|---|
| Price | $2.88 | $7.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $3.00 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 2.7M | 225.3K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.25 | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | $52,776,000.00 | ★ $109,429,000.00 |
| Revenue This Year | $11.10 | $3.88 |
| Revenue Next Year | $11.92 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.80 | $4.54 |
| 52 Week High | $3.71 | $22.25 |
| Indicator | STIM | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.78 | 51.94 |
| Support Level | $1.21 | $5.85 |
| Resistance Level | N/A | $8.26 |
| Average True Range (ATR) | 0.16 | 0.45 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 33.05 | 12.06 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.